A61K 47/544
Phospholipids
Official title: {Phospholipids}
A61K47/544 (Phospholipids) appears on 495 US grants and 693 published applications in this corpus.
Search patents in A61K- Granted patents
- 495
- Published applications
- 693
- Assignees
- 318
- Inventors
- 1,113
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 7 | 0 |
| 1997 | 5 | 0 |
| 1998 | 14 | 0 |
| 1999 | 14 | 0 |
| 2000 | 21 | 0 |
| 2001 | 10 | 4 |
| 2002 | 17 | 15 |
| 2003 | 10 | 22 |
| 2004 | 8 | 17 |
| 2005 | 8 | 29 |
| 2006 | 13 | 27 |
| 2007 | 4 | 15 |
| 2008 | 6 | 22 |
| 2009 | 8 | 13 |
| 2010 | 8 | 18 |
| 2011 | 12 | 17 |
| 2012 | 11 | 30 |
| 2013 | 10 | 26 |
| 2014 | 18 | 32 |
| 2015 | 28 | 40 |
| 2016 | 41 | 51 |
| 2017 | 22 | 35 |
| 2018 | 31 | 26 |
| 2019 | 17 | 19 |
| 2020 | 18 | 30 |
| 2021 | 16 | 29 |
| 2022 | 11 | 34 |
| 2023 | 18 | 33 |
| 2024 | 16 | 54 |
| 2025 | 18 | 31 |
| 2026 | 8 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Liposomal formulations comprising AT1 receptor blockers and uses thereof25 Aug 2026US 12,714,669 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- MRNA-loaded lipid nanoparticles and processes of making the same4 Aug 2026US 12,697,309 B2Translate Bio, Inc.
- Varicella zoster virus (VZV) vaccine12 May 2026US 12,622,960 B2ModernaTX, Inc.
- Methods and immunogenic compositions relating to HER2 with selective sequence modifications28 Apr 2026US 12,611,463 B2Wayne State University
- Drug-clay mineral complex containing phospholipid and oral administration composition including same21 Apr 2026US 12,605,449 B2Korea Institute of Geoscience and Mineral Resources
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Biologically compatible, biofilm disrupting composition and methods1 Oct 2026US 2026/0294861 A1
- Cpg amphiphiles and uses thereof3 Sep 2026US 2026/0258090 A1Elicio Therapeutics, Inc.
- Phospholipid compounds and formulations27 Aug 2026US 2026/0248830 A1AVVIO Medical, Inc.
- Analgesic compositions, method of manufacture and uses thereof30 Jul 2026US 2026/0216214 A1
Most cited
By later US patents
- Cationic lipids for intracellular delivery of biologically active molecules586US 5,459,127 AVical Incorporated · 1995
- Cationic lipids for intracellular delivery of biologically active molecules545US 5,264,618 AVical Incorporated · 1993
- Charged lipids and uses for the same361US 6,120,751 AImaRx Pharmaceutical Corp. · 2000
- Lipopolyamines, their preparation and their use287US 5,171,678 ACentre National De La Recherche Scientifique · 1992
- Liponucleotide-containing liposomes280US 5,223,263 AVical Incorporated · 1993